Trials / Unknown
UnknownNCT04497831
Morphine for Dyspnea in Pulmonary Fibrosis
Determining the Effectiveness of Nebulized Morphine in Treating Dyspnea in Advanced Idiopathic Pulmonary Fibrosis
- Status
- Unknown
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 20 (estimated)
- Sponsor
- Medical University of Gdansk · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
"Determination of the effectiveness of nebulized morphine in the treatment of dyspnea in patients with advanced idiopathic pulmonary fibrosis"
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Morphine hydrochloride | 5 mg milligram(s) per day per two days of dosage |
| DRUG | Placebo | Inhalation use |
Timeline
- Start date
- 2020-09-21
- Primary completion
- 2022-09-21
- Completion
- 2022-09-21
- First posted
- 2020-08-04
- Last updated
- 2020-08-04
Source: ClinicalTrials.gov record NCT04497831. Inclusion in this directory is not an endorsement.